Alcami Donates to Wilmington Firefighters' Cancer Detection
Alcami, a product development and manufacturing-services provider for the pharmaceutical and biotechnology industries, employs more than 450 people at its laboratory in Wilmington.
According to the Firefighter Cancer Support Network, firefighters have a 9 percent higher risk of being diagnosed with cancer than the general U.S. population
"The men and women of the Wilmington Fire Department are honored to be recognized by way of this donation," said Wilmington Fire Chief Buddy Martinette in a statement. "Our brave personnel face many known dangers on a daily basis. Unfortunately, it could very well be our greatest dangers are, in fact, the carcinogens in the byproducts of combustion that can not only be inhaled, but also absorbed into our skin. The results of this are a very high percentage of cancer among fighters compared to the general public. I am afraid this trend will continue and become a future epidemic in our profession."
The IvyGene test is owned by Laboratory for Advanced Medicine, an Irvine, California-based biotechnology laboratory specializing in the early diagnosis and intervention of cancers. The blood test detects the presence of cancer and gives quantifiable data about cancer presence. IvyGene uses advanced DNA sequencing methods to detect the DNA methylation pattern of cell free DNA in blood. The sequence along with the pattern of methylated DNA are consistent with cancer presence.
The fire department hopes to raise $65,000 to provide IvyGene testing for its 200 firefighters.